(PRAS) Amundi Index Solutions - Ratings and Ratios
US Government Bonds Exposure, Fixed Income Investments
Description: PRAS Amundi Index Solutions
Amundi Index Solutions Amundi Prime US Treasury UCITS ETF DR (C) is an exchange-traded fund (ETF) that tracks the Morningstar US Govt Bd TR USD index, providing investors with exposure to US government bonds. The fund is domiciled in Germany and is designed to offer a diversified portfolio of high-quality, liquid US Treasury securities.
The ETFs investment objective is to replicate the performance of the underlying index, which comprises a broad range of US government bonds. By doing so, it aims to provide investors with a stable source of returns, while minimizing credit risk through its focus on high-quality government debt.
Analyzing the funds characteristics, we can infer that it is a suitable investment for those seeking to hedge against market volatility or to diversify their portfolios with high-quality fixed income securities. The funds Assets Under Management (AUM) stand at €75.70M, indicating a moderate level of investor interest.
From a technical analysis perspective, the ETFs price action suggests a short-term bullish trend, as the current price of $17.61 is above the 20-day Simple Moving Average (SMA) of $17.42. However, the 50-day SMA ($17.79) and 200-day SMA ($18.10) indicate a longer-term bearish trend. The Average True Range (ATR) of 0.16 (0.90%) suggests relatively low volatility.
Combining technical and fundamental analysis, we can forecast that the ETFs price is likely to face resistance around the 50-day SMA ($17.79) and may potentially break through to the upside if the overall market sentiment improves. Conversely, a decline below the 20-day SMA ($17.42) could signal a further decline towards the 52-week low of $17.10. Given the current AUM and the ETFs tracking of a high-quality government bond index, we expect the fund to remain a stable investment option for investors seeking US Treasury exposure.
Based on the available data, a potential trading strategy could involve monitoring the ETFs price action around the 50-day SMA ($17.79) and adjusting positions accordingly. A break above this level could be seen as a buying opportunity, while a decline below the 20-day SMA ($17.42) may warrant a more cautious approach.
Additional Sources for PRAS ETF
PRAS ETF Overview
Market Cap in USD | 89m |
Category | USD Government Bond |
TER | 0.05% |
IPO / Inception | 2019-02-05 |
PRAS ETF Ratings
Growth Rating | -26.2 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -0.75 |
Analysts | - |
Fair Price Momentum | 15.49 EUR |
Fair Price DCF | - |
PRAS Dividends
Currently no dividends paidPRAS Growth Ratios
Growth Correlation 3m | -79.7% |
Growth Correlation 12m | -24.1% |
Growth Correlation 5y | -20% |
CAGR 5y | -2.47% |
CAGR/Max DD 5y | -0.19 |
Sharpe Ratio 12m | -1.60 |
Alpha | -7.53 |
Beta | -0.127 |
Volatility | 95.70% |
Current Volume | 0k |
Average Volume 20d | 1.1k |
Stop Loss | 16.3 (-3.4%) |
As of July 09, 2025, the stock is trading at EUR 16.87 with a total of 36 shares traded.
Over the past week, the price has changed by -0.15%, over one month by -1.79%, over three months by -6.93% and over the past year by -4.02%.
Probably not. Based on ValueRay´s Analyses, Amundi Index Solutions (XETRA:PRAS) is currently (July 2025) not a good stock to buy. It has a ValueRay Growth Rating of -26.16 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PRAS is around 15.49 EUR . This means that PRAS is currently overvalued and has a potential downside of -8.18%.
Amundi Index Solutions has no consensus analysts rating.
According to our own proprietary Forecast Model, PRAS Amundi Index Solutions will be worth about 16.7 in July 2026. The stock is currently trading at 16.87. This means that the stock has a potential downside of -0.83%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 16.7 | -0.8% |